SAN CARLOS, Calif., March 3, 2015 /PRNewswire/ — Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation research, today announced it has two posters scheduled to be presented during the 2015 American Society for Clinical Pharmacology and Therapeutics meeting in New Orleans, LA March 3-7 2015.
Logo – http://photos.prnewswire.com/prnh/20150302/179058LOGO
Bristol-Myers Squibb and Rosa will present a poster describing a quantitative systems pharmacology approach for immuno-oncology drug development at the ASCPT 2015 Annual Meeting in New Orleans, LA. The poster, entitled "Development of a quantitative systems pharmacology platform to support translational research and clinical development in immuno-oncology" will be presented by Brian Schmidt, Ph.D. Senior Research Investigator, Bristol-Myers Squibb during the Quantitative Systems Pharmacology Pre-Conference Poster Session on Tuesday, March 3, 2015, 12:45 PM – 1:45 PM at the Hyatt Regency, Elite Foyer and during the Late-Breaking and Encore Poster Session I on Friday, March 6, 2015, 4:30 – 6:30 PM at the Hyatt Regency, Elite Hall. (Abstract)
A second poster, entitled "Virtual Systems Pharmacology (ViSP) flexible web-based environment for running large multi-scale models" describing a ViSP web-based environment will be presented by Tarek Leil, Ph.D. Group Director, Bristol-Myers Squibb during the Quantitative Systems Pharmacology Pre-Conference Poster Session on Tuesday, March 3, 2015, 12:45 PM – 1:45 PM at the Hyatt Regency, Elite Foyer and during the Late-Breaking and Encore Poster Session I on Thursday, March 5th, 2015 from 4:30 – 6:30 PM at the Hyatt Regency, Elite Hall. (Abstract)
After each poster has been presented at the ASCPT Annual Meeting, Rosa will post links to the individual presentations at its website at: www.rosaandco.com/news.
"We are pleased to share the groundbreaking work from our collaboration with Bristol-Myers Squibb, and are honored that our submitted poster presentations were accepted for inclusion in the ASCPT 2015 meeting." – Dr. Mike Reed, Rosa & Co. Chief Scientist
About Rosa
Rosa helps clients with their critical decisions – from preclinical through clinical development – with creation and use of mathematical models that simulate normal and disease physiology, drug action, patient variability, and trial outcomes. Addressing the full spectrum of R&D related challenges from targets to outcomes, Rosa offers customized innovative PhysioPD™ Research Platforms. Rosa's clients participate in Platform creation, testing, and biological simulation research. Clients retain the Platforms to perform research to inform decisions and better understand implications for their drug development programs. Rosa's staff has unparalleled professional experience applying biological modeling and simulation research to accelerate drug development and has completed hundreds of engagements with clients in virtually all therapeutic areas. Rosa is unique in its breadth and depth of disease area experience, including metabolic diseases, immuno-oncology, oncology, inflammation, immune dysfunction, central nervous system disorders, dermatology, and antibacterial/antiviral biology. For more information, visit www.rosaandco.com.
Rosa and the Rosa logo are registered trademarks of Rosa & Co. LLC.
Media Contact:
Sharan Pagano
spagano@rosaandco.com